Why it was recalled
Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
Product description
Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98
Lot numbers, UPCs & expiration codes
Lot # NB240316, Exp 12/31/25
Where it was sold
USA nationwide.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0043-2025
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Oct 23, 2024
- FDA report date
- Nov 20, 2024
- Quantity
- 1,875 boxes (cipla and exlan)
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Cipla USA, Inc.
Original FDA data
Every field from FDA enforcement report D-0043-2025, exactly as published.
Show all FDA fields
- City
- Warren
- State
- NJ
- Status
- Ongoing
- Country
- United States
- Event ID
- 95611
- Address
- 10 Independence Blvd
- Code information
- Lot # NB240316, Exp 12/31/25
- Postal code
- 07059-2730
- Report date
- Nov 20, 2024
- Product type
- Drugs
- Recall number
- D-0043-2025
- Classification
- Class II
- Recalling firm
- Cipla USA, Inc.
- Product quantity
- 1,875 boxes (cipla and exlan)
- Reason for recall
- Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98
- Distribution pattern
- USA nationwide.
- Recall initiation date
- Oct 23, 2024
- Initial firm notification
- Letter
- Center classification date
- Nov 12, 2024